Jane Street’s DICE Therapeutics DICE Stock Holding History
Bought
Maintained
Sold
Jane Street's DICE Position: Q3 2023 in Review
Jane Street sold out of DICE Therapeutics (DICE) in Q3 2023, closing a stake of 22,740 shares — an estimated $1.06M sold.
Jane Street first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $1.06M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.
- Jane Street reported no remaining DICE Therapeutics position as of Q3 2023 after selling out during the quarter.
- Jane Street sold 22,740 DICE Therapeutics shares in Q3 2023, an estimated $1.06M.
- Jane Street first reported a position in DICE Therapeutics in Q4 2022 and held it in 3 quarters.
- Jane Street's DICE Therapeutics position peaked at $1.06M in Q2 2023.
- 0 funds tracked by Wall St. Rank held DICE Therapeutics as of Q3 2023.
Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.